Journal of Ophthalmology

Research Article

Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion

Table 1

Baseline characteristics of the studied eyes.


	Alternate group (n = 33)	Anti-VEGF group (n = 79)

Males, n (%)	12 (36.4%)	33 (41.8%)	0.595^a
Age, years (mean ± SD)	69.1 ± 11.5	66.8 ± 11.0	0.332^b
Diabetes	8 (24.2%)	11 (13.9%)	0.185^a
Retinal vein occlusion, n (%)
BRVO	23 (69.7%)	45 (57.0%)	0.208^a
CRVO	10 (30.3%)	34 (43.0%)	0.208^a
Baseline BCVA (logMAR)	0.90 ± 0.58	0.80 ± 0.48	0.364^b
Baseline CMT (μm)	569.5 ± 258.5	561.1 ± 232.9	0.866^b
Pseudophakic, n (%)	7 (21.2%)	13 (16.5%)	0.549^a
IOP, mmHg	12.1 ± 3.4	11.9 ± 3.6	0.787^b
Prior treatment, n (%)
Focal laser	1 (3.0%)	1 (1.3%)	0.504^c
Peripheral scatter laser	2 (6.1%)	1 (1.3%)	0.207^c

BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion; BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; CMT, central macular thickness; IOP, intraocular pressure. ^a values were calculated using the Chi-square test. ^b values were calculated using the Mann–Whitney U-test. ^c values were calculated using the Fisher’s exact test.